Men's Health

Latest News

Label change for testosterone: Implications for urologists, prescribers, and patients
Label change for testosterone: Implications for urologists, prescribers, and patients

April 9th 2025

In February 2025, the FDA recommended a removal of the black box warning related to an increased risk of adverse cardiovascular outcomes for all testosterone products. This recommendation has important implications for urologists and the patients they treat.

Study links poor semen quality with shorter life span
Study links poor semen quality with shorter life span

March 5th 2025

FDA issues labeling changes for testosterone products following TRAVERSE, postmarket studies
FDA issues labeling changes for testosterone products following TRAVERSE, postmarket studies

March 3rd 2025

US FDA logo in white over a blue background. | Credit: US Food and Drug Administration
FDA Updates in Urology: January 2025

February 4th 2025

FDA market clearance sought for Separo sealing system for vasectomy
FDA market clearance sought for Separo sealing system for vasectomy

January 29th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.